0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata pharmapoint rheumatoid arthritis global drug forecast market analysis 2025.Your search for "" gave back 1533058 results.
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report 'Interleukin 1 - Drugs in Development, 2021...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Treatment of drugs for regulating rheumatic diseases The “Rheumatic Disorders Drug Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Pipeline Review, H2 2018 Summary According to the recently...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
The global Arthritic Therapeutic market was valued at US$ 27240 million in 2023 and is anticipated to reach US$ 35210 million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2018 Summary...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is mainly employed to treat mild-to-moderate pain & reduces pain, inflammation...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019 Summary According to the recently published report 'Interleukin 1 Receptor...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Treatment of drugs for regulating rheumatic diseases Highlights The global Rheumatic Disorders Drug market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
